Publication | Closed Access
Inhibition of Platelet Function by Uremic Middle Molecules
48
Citations
0
References
1985
Year
Platelet AbnormalitySerum FractionsPlatelet AggregationThrombosisPlatelet ConcentratesHematologyClinical ChemistryPlatelet AntagonistChronic Kidney DiseaseAtherosclerosisHealth SciencesVascular BiologyPharmacologyUremic Middle MoleculesThrombopoiesisPlatelet ActivationUrologyBlood PlateletPhysiologyHemostasisCoagulopathyMedicineNephrology
To further define the platelet abnormality responsible for uremic bleeding, we studied platelet aggregation with adenosine diphosphate, ristocetin, and collagen in serum fractions obtained by Sephadex G-15 chromatography. We found that uremic patients had considerable inhibition in several peaks of middle molecular range, but the findings were inconsistent and not clearly related to the degree of uremia.